Feeds

EU will fund stem cell science

But there's a catch

Bridging the IT gap between rising business demands and ageing tools

The EU yesterday decided not to follow the Bush administration's lead and declined to impose a blanket ban on federal funding of scientists doing research on embryonic stem cells.

The politicians disappointed scientists, however, by refusing to allow EU cash to be used in projects which involve harvesting stem cells from surplus IVF embryos. Religious and pro-life lobbyists argue this constitutes taking human life, though scientists argue the embryos are currently destroyed when not required by an infertile couple.

In a statement, UK scientists' body the Royal Society said: "It remains to be seen what impact these limitations will have on stem cell research given that they impose greater restrictions than currently exist for EU research funding. It also remains to be seen whether the European Parliament approves these restrictions in November."

A qualified majority voted for proposals which do not include harvesting cells to be included in the £37bn 2007 to 2013 research budget. Poland, Austria, Malta, Slovakia and Lithuania voted against funding the entire field. The German research minister who had earlier told the meeting: "We must conserve human life from its conception. We want no financial incentives to kill embryos," accepted the compromise to fund every stage of stem cell science bar the first.

Speaking to The Guardian, Stephen Hawking, who famously suffers from motor neurone disease, described the EU settlement as a "fudge".

National governments remain free to fund scientists as they wish. The UK research councils have already given funding to therapeutic cloning projects, similar to those faked in Korea by Hwang Woo-Suk.

The worry among academics is that the EU funding restrictions will make pan-European cooperation more difficult, and so slow progress towards cures for debilitating diseases such as Parkinson's. ®

Mobile application security vulnerability report

More from The Register

next story
Bad back? Show some spine and stop popping paracetamol
Study finds common pain-killer doesn't reduce pain or shorten recovery
Malaysian Airlines flight MH17 claimed lives of HIV/AIDS cure scientists
Researchers, advocates, health workers among those on shot-down plane
Mwa-ha-ha-ha! Eccentric billionaire Musk gets his PRIVATE SPACEPORT
In the Lone Star State, perhaps appropriately enough
SMELL YOU LATER, LOSERS – Dumbo tells rats, dogs... humans
Junk in the trunk? That's what people have
All those new '5G standards'? Here's the science they rely on
Radio professor tells us how wireless will get faster in the real world
The Sun took a day off last week and made NO sunspots
Someone needs to get that lazy star cooking again before things get cold around here
Boffins discuss AI space program at hush-hush IARPA confab
IBM, MIT, plenty of others invited to fill Uncle Sam's spy toolchest, but where's Google?
prev story

Whitepapers

Designing a Defense for Mobile Applications
Learn about the various considerations for defending mobile applications - from the application architecture itself to the myriad testing technologies.
How modern custom applications can spur business growth
Learn how to create, deploy and manage custom applications without consuming or expanding the need for scarce, expensive IT resources.
Reducing security risks from open source software
Follow a few strategies and your organization can gain the full benefits of open source and the cloud without compromising the security of your applications.
Boost IT visibility and business value
How building a great service catalog relieves pressure points and demonstrates the value of IT service management.
Consolidation: the foundation for IT and business transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.